Efficacy assessments included TWSTRS total ( primary end point ) and subscale scores at weeks @ , @ , @ , @ ; a pain visual analogue scale at weeks @ and @ ; and HRQOL assessed by the SF-@ Health Survey ( SF-@ ; secondary end point ) at weeks @ and @ .